Yugaku Daté

发表

Extremely Low Prevalence of Amyloid Positron Emission Tomography Positivity in Parkinson's Disease without Dementia

M. Jinzaki, M. Kameyama, D. Ito, 2017, European Neurology.

Ropinirole hydrochloride for amyotrophic lateral sclerosis: A single-center, randomized feasibility, double-blind, placebo-controlled trial

M. Jinzaki, D. Ito, N. Suzuki, 2021, medRxiv.

Influence of a clinical trial in the decision-making processes of patients with amyotrophic lateral sclerosis

H. Okano, J. Nakahara, K. Okada, 2021, Journal of Neurology.

Meningitis caused by Listeria monocytogenes in a locally advanced cervical cancer patient with pyometra: A case report

D. Aoki, K. Masuda, K. Banno, 2021, Gynecologic oncology reports.

The utility of simple questions to evaluate cognitive impairment

M. Mimura, D. Ito, Yoko Eguchi, 2020, PloS one.

Phase 1/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery.

H. Okano, M. Jinzaki, D. Ito, 2023, Cell stem cell.

Anaphylactoid reaction to immunoadsorptive membrane in a patient with myasthenia gravis

Shigeaki Suzuki, N. Suzuki, M. Hayashi, 2012, CEN Case Reports.

Extremely Low Prevalence of Amyloid Positron Emission Tomography Positivity in Parkinson's Disease without Dementia

M. Jinzaki, M. Kameyama, D. Ito, 2017, European Neurology.

Proteomic insights into extracellular vesicles in ALS for therapeutic potential of Ropinirole and biomarker discovery

Shiho Nakamura, Fumiko Ozawa, Yugaku Daté, 2024, Inflammation and regeneration.